• Phase II Results Promising for New Schizophrenia Drug Combo

    1 month ago - By MedPageToday

    Phase II results appear promising for a new combination treatment for schizophrenia.
    Findings from previous studies have shown that the muscarinic receptor agonist xanomeline could be used as a novel way to treat psychosis that...
    Read more ...